ATHIX | PMBJX | ATHIX / PMBJX | |
Total Expense Ratio | 0.80 | 0.78 | 103% |
Annual Report Gross Expense Ratio | 0.80 | 0.78 | 103% |
Fund Existence | 28 years | 25 years | - |
Gain YTD | 10.051 | 2.303 | 436% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000000 | 1000 | 500,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.1B | 31.9B | 19% |
Annual Yield % from dividends | 0.00 | 0.06 | - |
Returns for 1 year | 0.84 | -3.03 | -28% |
Returns for 3 years | 50.47 | 48.67 | 104% |
Returns for 5 years | 5.50 | 34.98 | 16% |
Returns for 10 years | 18.87 | 98.61 | 19% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XPH | 48.20 | 0.19 | +0.40% |
SPDR® S&P Pharmaceuticals ETF | |||
DFUV | 44.24 | 0.13 | +0.29% |
Dimensional US Marketwide Value ETF | |||
TXS | 36.05 | 0.03 | +0.08% |
Texas Capital Texas Equity Index ETF | |||
LFAI | 155.51 | N/A | N/A |
LifeX 2050 Longevity Income ETF | |||
ISHG | 75.86 | -0.06 | -0.08% |
iShares 1-3 Year International TrsBd ETF |